Evidence map›Paper›PMID 37892755›Full record

ArticleJournal of clinical medicine2023

Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review.

Matteo Regolo, Nicolas Cardaci, Clara Salmeri, Alfredo Laudani, Michele Colaci, Massimo Ippolito, Fabio Motta, Salvatore Magrì, Stefanie Parisi, Alfredo Gaetano Torcitto and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Dosimetry inJournal of clinical medicine · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Matteo RegoloDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0003-3485-5181
Nicolas CardaciDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.
Clara SalmeriDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.
Alfredo LaudaniDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.
Michele ColaciDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0002-3606-3404
Massimo IppolitoNuclear Medicine Unit, Cannizzaro Hospital, 95126 Catania, Italy.
Fabio MottaPathological Anatomy Unit, Cannizzaro Hospital, 95126 Catania, Italy.
Salvatore MagrìEndoscopy Unit, Cannizzaro Hospital, 95126 Catania, Italy.ORCID 0000-0001-5635-069X
Stefanie ParisiEndoscopy Unit, Cannizzaro Hospital, 95126 Catania, Italy.
Alfredo Gaetano TorcittoRadiology Unit, Cannizzaro Hospital, 95126 Catania, Italy.
Lorenzo MalatinoDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0003-2944-2729
University of Catania · ITOspedale Cannizzaro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A pancreatic neuroendocrine tumor (Pan-NET) is a rare neoplasm originating in the neuroendocrine system. Carcinoid syndrome occurs in approximately 19% of patients with functional Pan-NETs, typically when liver metastases occur. In this paper, we describe the case of a patient with a low-grade non-functional Pan-NET, but with a typical clinical presentation of carcinoid syndrome. An 81-year-old male was admitted to our Department of Internal Medicine at Cannizzaro Hospital (Catania, Italy) because of the onset of abdominal pain with nausea, loose stools, and episodic flushing. Firstly, an abdominal contrast-enhanced CT scan showed a small pancreatic hyper-vascular mass; then, a gallium-68 DOTATOC integrated PET/CT revealed an elevated expression of SSTR receptors. Serum chromogranin A and urinary 5-HIAA measurements were negative. We performed an endoscopic ultrasonography (EUS) by a fine-needle biopsy (EUS-FNB), allowing the immunostaining of a small mass (0.8 cm) and the diagnosis of a low-grade (G1) non-functional Pan-NET (NF-Pan-NET). Surgery was waived, while a follow-up strategy was chosen. The early recognition of Pan-NETs, although rare, is necessary to improve the patient's survival. Although helpful to allow for immunostaining, EUS-FNB needs to be warranted in future studies comparing EUS-FNB to EUS-FNA (fine-needle aspiration), which is, to date, reported as the tool of choice to diagnose Pan-NETs.

Indexed as

endoscopic ultrasonographyEUS-FNAEUS-FNBneuroendocrine tumors (NETs)pancreatic neuroendocrine tumors (Pan-NETs)

Identifiers

PMID37892755
PMCPMC10607714
OpenAlexW4387781013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.